MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls

The NAS and histological drivers of fibrosis (e.g. inflammation and hepatocyte ballooning) are less pronounced in MASLD-PWH, and yet fibrosis stage was generally higher when compared to matched controls with MASLD without HIV. This suggests HIV-specific factors beyond hepatic necroinflammation may contribute to fibrosis progression in MASLD-PWH.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2024-09-05
DOI
https://doi.org/10.1111/apt.18236
Citations
14
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
5.41

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls

Daniela Allende, Oscar W. Cummings, Patricia Belt, David E. Kleiner et al.
14 citations
Alimentary Pharmacology & Therapeutics
Liver Disease Diagnosis and Treatment
5.41
article

MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls

Daniela Allende, Oscar W. Cummings, Patricia Belt, David E. Kleiner, Samer Gawrieh, Ryan M. Gill, Colleen Hadigan, Susanna Naggie, Rohit Seth Loomba, Jennifer C. Price, Cynthia A. Behling, Laura Wilson, Cynthia D. Guy, Holly Crandall, Matthew M. Yeh, Naga Chalasani, Danielle Carpenter, Richard K. Sterling, Mary McLaughlin
article en
14 citations

Abstract

The NAS and histological drivers of fibrosis (e.g. inflammation and hepatocyte ballooning) are less pronounced in MASLD-PWH, and yet fibrosis stage was generally higher when compared to matched controls with MASLD without HIV. This suggests HIV-specific factors beyond hepatic necroinflammation may contribute to fibrosis progression in MASLD-PWH.

Alimentary Pharmacology & TherapeuticsVol. 60(10)
Cleveland Clinic (US), Johns Hopkins University (US), Duke University (US), University of California, San Francisco (US), Virginia Commonwealth University (US), University of Washington (US), University Health System (US), University of California San Diego (US), Clinical Research Institute (US), Pacific Rim Engineering (United States) (US), National Institute of Allergy and Infectious Diseases (US), National Cancer Institute (US), Indiana University School of Medicine, Saint Louis University (US), Indiana University – Purdue University Indianapolis (US)
Pfizer, Ipsen, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences
Good health and well-being
Openalex Percentile: Top 4%
Liver Disease Diagnosis and Treatment
5.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.